Skip to main content
Signal8

FRIESON RON

SEC insider (Form 3/4/5 filer). CIK 0001890219. Director at Akebia Therapeutics, Inc. (AKBA). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in CAMBRIDGE, MA.

Companies FRIESON RON has filed insider reports for

  • Akebia Therapeutics, Inc. (AKBA): Director
FRIESON RON profile photo

FRIESON RON

CIK: 0001890219

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Akebia Therapeutics, Inc. logo
AKBA

Akebia Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Akebia Therapeutics, Inc. logo
    AKBA

    Akebia Therapeutics, Inc.

    Jun 17, 2026
    Award
    Direct
    35.7K shares-
  • Akebia Therapeutics, Inc. logo
    AKBA

    Akebia Therapeutics, Inc.

    Jun 10, 2025
    Award
    Direct
    35.7K shares-
  • Akebia Therapeutics, Inc. logo
    AKBA

    Akebia Therapeutics, Inc.

    Jan 17, 2025
    Exercise
    Direct
    20.1K shares at avg. $0.45$9K

1-3 of 3